CD38+HLA-DR+ mT cell frequencies have been shown to increase in chronic lymphocytic leukemia, gliomas, chronic infections, and immune disorders, where they are typically associated with a worse prognosis.73 This evidence concerns the gene CD38 and B-cell chronic lymphocytic leukemia.